Yan C - Search Results

1

CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer.

Kim YH, Byun YJ, Kim WT, Jeong P, Yan C, Kang HW, Kim YJ, Lee SC, Moon SK, Choi YH, Yun SJ, Kim WJ. Kim YH, et al. Among authors: yan c. J Korean Med Sci. 2018 Nov 2;33(47):e303. doi: 10.3346/jkms.2018.33.e303. eCollection 2018 Nov 19. J Korean Med Sci. 2018. PMID: 30450027 Free PMC article.

2

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.

Ha YS, Yan C, Jeong P, Kim WT, Yun SJ, Kim IY, Moon SK, Kim WJ. Ha YS, et al. Among authors: yan c. J Korean Med Sci. 2011 Feb;26(2):231-6. doi: 10.3346/jkms.2011.26.2.231. Epub 2011 Jan 24. J Korean Med Sci. 2011. PMID: 21286014 Free PMC article.

3

Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.

Yun SJ, Yan C, Jeong P, Kang HW, Kim YH, Kim EA, Lee OJ, Kim WT, Moon SK, Kim IY, Choi YH, Kim WJ. Yun SJ, et al. Among authors: yan c. Ann Surg Oncol. 2015 Jul;22(7):2439-45. doi: 10.1245/s10434-014-4194-4. Epub 2014 Oct 28. Ann Surg Oncol. 2015. PMID: 25348783

4

Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer.

Yan C, Kim YH, Kang HW, Seo SP, Jeong P, Lee IS, Kim D, Kim JM, Choi YH, Moon SK, Yun SJ, Kim WJ. Yan C, et al. J Korean Med Sci. 2015 Dec;30(12):1784-92. doi: 10.3346/jkms.2015.30.12.1784. Epub 2015 Nov 30. J Korean Med Sci. 2015. PMID: 26713053 Free PMC article.

5

Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.

Kim YH, Yan C, Lee IS, Piao XM, Byun YJ, Jeong P, Kim WT, Yun SJ, Kim WJ. Kim YH, et al. Among authors: yan c. Investig Clin Urol. 2016 Mar;57(2):106-12. doi: 10.4111/icu.2016.57.2.106. Epub 2016 Mar 11. Investig Clin Urol. 2016. PMID: 26981592 Free PMC article.

6

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.

Kim WT, Jeong P, Yan C, Kim YH, Lee IS, Kang HW, Kim YJ, Lee SC, Kim SJ, Kim YT, Moon SK, Choi YH, Kim IY, Yun SJ, Kim WJ. Kim WT, et al. Among authors: yan c. Oncotarget. 2016 Sep 6;7(36):58193-58202. doi: 10.18632/oncotarget.11277. Oncotarget. 2016. PMID: 27528424 Free PMC article.

7

S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy.

Kim WT, Kim J, Yan C, Jeong P, Choi SY, Lee OJ, Chae YB, Yun SJ, Lee SC, Kim WJ. Kim WT, et al. Among authors: yan c. Ann Oncol. 2014 May;25(5):974-9. doi: 10.1093/annonc/mdu037. Epub 2014 Mar 14. Ann Oncol. 2014. PMID: 24631944 Free article.

8

Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: a novel approach using peptide nucleic acid-mediated, real-time PCR clamping.

Kim EJ, Yan C, Ha YS, Jeong P, Yi Kim I, Moon SK, Choi YH, Kim WJ. Kim EJ, et al. Among authors: yan c. Urol Oncol. 2012 Sep;30(5):673-9. doi: 10.1016/j.urolonc.2010.07.008. Epub 2010 Sep 29. Urol Oncol. 2012. PMID: 20884250

9

GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.

Ha YS, Yan C, Lym MS, Jeong P, Kim WT, Kim YJ, Yun SJ, Lee SC, Moon SK, Choi YH, Kim WJ. Ha YS, et al. Among authors: yan c. Dis Markers. 2010;29(2):81-7. doi: 10.3233/DMA-2010-0729. Dis Markers. 2010. PMID: 21045267 Free PMC article.

10

GSTT1: a marker of the aggressiveness of bladder cancer.

Ha YS, Yan C, Park C, Yun SJ, Moon SK, Choi YH, Kim WJ. Ha YS, et al. Among authors: yan c. Urol Int. 2011;86(1):41-6. doi: 10.1159/000321689. Epub 2010 Nov 16. Urol Int. 2011. PMID: 21079384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,728 results

Search Page

Filters